Innovation In the Chest Pain Pathway – How NHS England Is Leading the Way With Cardiac CT and Artificial Intelligence
Published: 24 March 2022
-
Views:
34258
-
Likes:
7
-
Views:
34258
-
Likes:
7
Overview
According to NICE, HeartFlow FFRct should be considered as an option for patients with stable, recent-onset chest pain who are offered CCTA. Using HeartFlow FFRct may avoid the need for invasive coronary angiography and revascularisation.
Based on the current evidence and assuming there is access to appropriate CCTA facilities, using HeartFlow FFRct may lead to cost savings of £391 per patient [2021].
https://www.nice.org.uk/guidance/mtg32/
During this video series, you will learn more about the GIRFT report and its recommendations to understand the role of CT and FFRct as a way to meet demand with capacity and deliver cost savings to the NHS in accordance with the NICE guidance.
In the third part, you will hear about the MedTech Funding Mandate and the experience of CCGs in adopting CT and FFRct to streamline the Chest Pain Pathway and reduce costs.
Find out more about HeartFlow at www.heartflow.com
Learning Objectives
- Explore the role of non invasive FFRct analysis
- Review clinical evidence supporting clinical utility health economics and safety of HeartFlow analysis
- Insights from high-volume centres in implementing a CT / FFRct pathway
- Learn More about the GIRFT report and its recommendations
- Understand the role of CT and FFRct as a way meet demand with capacity and deliver cost savings to the NHS in accordance with the NICE guidance
Target Audience
- Interventional and general cardiologists
- Cardiac imaging specialists and radiologists
- Cardiac Imagers
- Radiologists
- Cardiac CT specialists
- Commissioners
- NHS providers-clinical teams and corporate teams
- Integrated Care Boards /Systems
- AHSN's
- AHSN technology teams
More from this programme
Part 1
AI Powered CT Based Non Invasive CAD Testing – The Future Is Now
Part 2
Insights from the GIRFT Report: Innovation In the Chest Pain Pathway – How NHS England Is Leading the Way With Cardiac CT and Artificial Intelligence
Part 3
MedTech Funding Mandate and Commissioning Model: Innovation In the Chest Pain Pathway – How NHS England Is Leading the Way With Cardiac CT and Artificial Intelligence
Faculty Biographies
Carlos Collet
Interventional Cardiologist
Dr Carlos Collet practices as an interventional cardiologist at Olv Hospital Aalst, Aalst, BE.
Dr Collet earned a doctorate in Cardiovascular Sciences from the University of Amsterdam. During his doctoral studies, he devoted his research to the integration of coronary imaging and physiology in patients with complex coronary artery disease.
He has published over 300 peer-reviewed articles and serves as the co-director of the catheterisation laboratory at the Cardiovascular Center OLV Aalst in Belgium.
Jonathon Leipsic
University of British Columbia, Vancouver, British Columbia, Canada
Jonathon A Leipsic is Professor and Chair of Radiology and Professor of Cardiology at the University of British Columbia, Canada. Dr Leipsic is also a Canada Research Chair in Advanced Cardiopulmonary Imaging. Dr Leipsic has over 800 peer reviewed manuscripts in press or in print, over 300 scientific abstracts, and has edited two textbooks. He speaks internationally on a number of cardiopulmonary imaging topics, with over 150 invited lectures in the last four years. He is also a past President of the Society of Cardiovascular Computed Tomography (2015-2016) and was awarded its Gold Medal in 2019. He was recently named for the fifth consecutive year (2019-2023) a prestigious 'Top 1%' most impactful scientist, as designated by the Web of Science.